Cellarim Labs raises ₹6 crore to scale India-made hyaluronic acid for beauty brands

Bengaluru-based Cellarim Labs will use its seed round to build a pilot facility and begin commercial B2B supply of NeuHyal, a cell-free, bio-waste-derived hyaluronic acid ingredient positioned as an alternative to imported cosmetic inputs.

— Source publishedThu, 30 Jul, 2026, 16:00 IST·First seen Thu, 30 Jul, 2026, 16:06 IST·Source YourStory · Capital

What happened

Bengaluru-based Cellarim Labs raised ₹6 crore to build a pilot facility and commercially supply its cell-free, bio-waste-derived hyaluronic acid ingredient

Key facts

  • ₹6 crore seed round announced in December 2025
  • approximately $830,000 total funding
  • founded in 2023; incorporated on 26 December 2023
  • NeuHyal molecular-weight range: 10 kDa to 5,000 kDa
  • company claims over 95% yield, 90% less water use, 95% fewer emissions and 80% lower cost versus precision fermentation

Why this matters

Beauty and ingredient companies may want to track Cellarim as a potential domestic supply or partnership target once NeuHyal’s pilot production and quality credentials are validated.

What to watch

  • Pilot facility commissioning date and whether commercial batches begin within the stated funding runway.
  • Named customer trials, formulation launches or supply agreements with beauty brands or contract manufacturers.
  • Published technical specifications, third-party assay results and batch-to-batch consistency data for NeuHyal.
  • Pricing disclosures or customer commentary indicating a meaningful cost, MOQ or lead-time advantage over imported material.
  • Regulatory, certification or quality-system milestones that reduce procurement risk for large beauty companies.
  • Follow-on financing, strategic investment or manufacturing partnerships indicating successful scale-up validation.
  • Responses from established ingredient distributors and imported hyaluronic-acid suppliers, including local stocking, lower MOQs or pricing adjustments.
  • Commission the pilot plant and publish target annual capacity, commissioning timeline and intended hyaluronic-acid grades.
  • Secure third-party testing for purity, endotoxins, microbial limits, heavy metals, molecular-weight distribution and formulation stability.
  • Obtain or pursue relevant cosmetic ingredient and quality certifications, including GMP-aligned manufacturing processes and documentation needed by brand regulatory teams.
  • Convert sampling activity into supply agreements or co-development pilots with Indian beauty brands, contract manufacturers and dermatology-led skincare companies.
  • Demonstrate landed-cost competitiveness versus imported hyaluronic acid after accounting for customs, freight, lead times, MOQs and inventory carrying costs.
  • Build feedstock, purification and quality-control redundancy before pursuing larger commercial capacity or export customers.